|
|
Article: Adherence to Lipid-Lowering Drug Therapy among Members of the Canadian Forces
- Article from:
- Military Medicine
- Article date:
- July 1, 2008
- Author:
CopyrightCopyright Association of Military Surgeons of the United States Jul 2008. Provided by ProQuest LLC. (Hide copyright information)
|
ABSTRACT Objective: This study was performed to quantify adherence rates to lipid-lowering drug therapy among members of the Canadian Forces (CF) and to identify factors associated with nonadherence. Methods: Pharmacy claims were reviewed for all CF members who received a lipid-lowering drug between April 1 and June 1, 2003. Subjects were categorized as adherent if records indicated consumption of at least 80% of prescribed doses. Logistic regression was performed to assess the impact of patient and drug characteristics upon adherence. Results: Overall adherence rate at 1 year was 38.5% among all users of lipid-lowering medications. Adherence did not vary among the different classes of ...
Related newspaper, magazine, and journal articles:
|
|
Article: Bayer Withdraws Cholesterol-Lowering Drug ...
PR Newswire;
August 8, 2001 ;
700+ words
... ... Bayer has withdrawn all dosages of its cholesterol-lowering drug with the brand names Baycol/Lipobay (active ingredient ... segment resulting from the withdrawal of its cholesterol-lowering drug, as well as the continuing weakness of the world economy ...
|
|